证券记录 · 已归档季度
HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
20被追踪持有人
+1Δ持有人
24.69M持有股份
$680.58M报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +5.3% ·
股份流向 -0.8% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 21.01K | $831,838 | n/a | −2 |
| Q2 2026 | 111 | +5 | 37.63M | $1.37B | +12 | −8 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | n/a |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | n/a |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | n/a | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | n/a |
| Q2 2024 | 13 | n/a | 3.50M | $105.70M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 6.93M | +2.8% | $190.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (被动) | 5.10M | -0.3% | $140.48M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 3.85M | -17.9% | $106.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (被动) | 1.65M | +1.5% | $45.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.30M | +42.8% | $35.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 1.26M | +19.3% | $34.68M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 1.14M | +22.3% | $31.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 847.89K | n/a | $23.37M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 9 | Goldman Sachs Group ✦ | 646.65K | n/a | $17.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 355.57K | +133.9% | $9.80M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | JPMorgan Chase ✦ | 348.02K | n/a | $9.59M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 12 | Marshall Wace ✦ | 285.32K | -76.4% | $7.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | Two Sigma Investments ✦ | 225.29K | -5.7% | $6.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 211.53K | 新增 | $5.83M | 0.0% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 204.51K | +598.2% | $5.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 192.63K | -23.9% | $5.31M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 68.01K | 新增 | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 38.90K | -2.0% | $1.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 36.45K | +4.6% | $1.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Wellington Management ✦ | 19.27K | +22.5% | $531,136 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $5.83M | 0.0% |
| Citadel Advisors | $1.87M | 0.0% |
已清仓
| Point72 Asset Management | $1.07M | 曾为 0.0% |
| Norges Bank | $351,487 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 306 持有人, 54.70M 股份, $1.38B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 18
Budur Kumar
Officer · 35.85K 股 · $1.54M
Sep 17
Budur Kumar
Officer · 800 股 · $34,400
Sep 16
Budur Kumar
Officer · 1.80K 股 · $77,426
Sep 08
Budur Kumar
Officer · 22.95K 股 · $989,350
Sep 08
Budur Kumar
Officer · 1.00K 股 · $42,795
Sep 08
Budur Kumar
Officer · 4.50K 股 · $190,114
Sep 04
Budur Kumar
Officer · 5.50K 股 · $230,911
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 31
SC 13G: VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 28
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据